CClinicalTrials.gg
CompletedNCT05833685Updated Sep 26, 2023

Predicting Changes in Core Muscles During Female Sexual Dysfunction: A Comprehensive Analysis Using Machine and Deep Learning

An observational study in Female Sexual Dysfunction, sponsored by Deraya University. Completed at 1 site in Egypt. Open to female participants aged 30 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-09-26.

Sponsored by Deraya University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
30 Years to 40 Years
Sex
Female
01

Study summary

The purpose of this study is to Predicting changes in core muscles during female sexual dysfunction by A Comprehensive Analysis Using Machine and Deep Learning Female sexual dysfunction (FSD) is a common condition that affects womenof all ages. It is characterized by a range of symptoms, including decreased libido, difficulty achieving orgasm, and pain during intercourse. One potential cause of FSD is muscular weakness or changes in the core muscles. These muscles play an important role in sexual function, and changes in their strength or activation patterns can lead to FSD. Additionally, the development of a machine learning model for this purpose could pave the way for future studies exploring the use of artificial intelligence in the diagnosis and treatment of other musculoskeletal disorder and female health issues.

02

Conditions studied

  • Female Sexual Dysfunction

Keywords

  • Core Muscles, machine learning,female sexual dysfunction, KNN
03

In context

Lead sponsor

Deraya University is the lead sponsor of 48 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 40 Years
Sexes eligible
Female
Sampling method
Probability sample

Study population

100 patients were distributed randomly into two groups. Female sexual dysfunction group and another group is normal females. Two group will be measure Transverses muscle ratio, Multifidus muscle ratio ,diaphragm excursion and force of contraction of pelvic floor muscles by ultrasound imaging, VLQ and FSFI questionnaires for female sexual function VLQ and FSFI questionnaires for female sexual dysfunction and normal females. Patients will be examined by radiologist with medical ultrasound imaging

Inclusion criteria

  • a number of parities ≤ three
  • normal vaginal deliveries

Exclusion criteria

Exclusion Criteria:

  • History of a recto-vaginal or vesico-vaginal fistula, undiagnosed uterine bleeding urinary tract infection,
  • diabetes,
  • intrauterine device
  • sexual disorder
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Female sexual dysfunction group

    Other: no intervention

  • Normal females

    Other: no intervention

Interventions

  • Otherno intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Diaphragm excursion

    Ultrasound imaging curvilinear transducer

    Time frame: 2 months

Secondary outcomes

  1. Force of contraction of pelvic floor muscles

    ultrasound imaging, convex transducer was used at a frequency of 5 MHz for evaluating. Voluntary PFM contractions' force (strength) of all patients. It has a good inter-rater reliability for measuring PFM force (ICC, 0.81, 0.7123) respectively, as well as a good intra-rater reliability (ICC,0.98, 0.9841) respectively

    Time frame: 2 months

07

Study locations

1 site
  • Deraya university
    Minya, Minia, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05833685
Lead sponsor
Deraya University
Responsible party
Sponsor
First posted
Apr 27, 2023
Start date
Feb 1, 2023
Primary completion
Apr 10, 2023
Completion
Apr 15, 2023
Last update
Sep 26, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion